Prevalence and Antibiotic Susceptibility Trends of Selected <i>Enterobacteriaceae</i>, <i>Enterococci</i>, and <i>Candida albicans</i> in the Subgingival Microbiota of German Periodontitis Patients: A Retrospective Surveillance Study
The periodontal microbiota is ecologically diverse and may facilitate colonization by bacteria of enteric origin (<i>Enterobacteriaceae</i>, <i>Enterococci</i>) and co-infections with <i>Candida albicans</i>, possibly producing subgingival biofilms with high antim...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_8fea1ce199a8458e8a93fa1f07875a2b | ||
042 | |a dc | ||
100 | 1 | 0 | |a Karin Jepsen |e author |
700 | 1 | 0 | |a Wolfgang Falk |e author |
700 | 1 | 0 | |a Friederike Brune |e author |
700 | 1 | 0 | |a Raluca Cosgarea |e author |
700 | 1 | 0 | |a Rolf Fimmers |e author |
700 | 1 | 0 | |a Isabelle Bekeredjian-Ding |e author |
700 | 1 | 0 | |a Søren Jepsen |e author |
245 | 0 | 0 | |a Prevalence and Antibiotic Susceptibility Trends of Selected <i>Enterobacteriaceae</i>, <i>Enterococci</i>, and <i>Candida albicans</i> in the Subgingival Microbiota of German Periodontitis Patients: A Retrospective Surveillance Study |
260 | |b MDPI AG, |c 2022-03-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics11030385 | ||
500 | |a 2079-6382 | ||
520 | |a The periodontal microbiota is ecologically diverse and may facilitate colonization by bacteria of enteric origin (<i>Enterobacteriaceae</i>, <i>Enterococci</i>) and co-infections with <i>Candida albicans</i>, possibly producing subgingival biofilms with high antimicrobial tolerance. This retrospective surveillance study followed periodontitis-associated superinfection profiles in a large patient sample. From 2008 to 2015, biofilm samples from deep periodontal pockets were collected from a total of 16,612 German adults diagnosed with periodontitis. The presence of selected <i>Enterobacteriaceae</i>, <i>Enterococci</i>, and <i>Candida albicans</i> was confirmed in overnight cultures. Antimicrobial susceptibility of these clinical isolates was tested by disk diffusion with antibiotics routinely used for treatment of oral infections, e.g., amoxicillin (AML), amoxicillin/clavulanic acid (AMC), doxycycline (DO), and ciprofloxacin (CIP). The mean annual prevalence of patients harboring <i>Enterobacteriaceae</i> in periodontal plaques was 11.5% in total and ranged from 2.5% for <i>Enterobacter cloacae</i> to 3.6% for <i>Klebsiella oxytoca</i>, 1.1% for <i>Klebsiella pneumoniae</i>, 2.8% for <i>Serratia marcescens</i>, and 1.5% for <i>Serratia liquefaciens</i>. In comparison, the mean detection rates for microbiota typically found in the oral cavity were higher, e.g., 5.6% for <i>Enterococcus</i> spp. and 21.8% for <i>Candida albicans</i>. Among the <i>Enterobacteriaceae</i>, species harboring intrinsic resistance to AML (<i>Enterobacter</i> spp., <i>Klebsiella</i> spp., <i>Serratia</i> spp.) were predominant. Non-susceptibility to AMC was observed for <i>Serratia</i> spp. and <i>Enterobacter cloacae</i>. By contrast, <i>Enterococcus</i> spp. only showed non-susceptibility to DO and CIP. Trends for increasing resistance were found to AML in <i>Serratia liquefaciens</i> and to DO in <i>Enterococcus</i> spp. Trend analysis showed decreasing resistance to AMC in <i>Serratia liquefaciens</i> and <i>Klebsiella oxytoca</i>; and to DO in <i>Serratia marcescens, liquefaciens</i>, and <i>Enterobacter cloacae</i>. This study confirms the low but consistent presence of <i>Enterobacteriaceae</i> and <i>Enterococci</i> among the subgingival microbiota recovered from periodontitis specimen. Although their pathogenetic role in periodontal lesions remains unclear, their presence in the oral cavity should be recognized as a potential reservoir for development and spread of antibiotic resistance in light of antibiotic usage in oral infections. | ||
546 | |a EN | ||
690 | |a antibiotics | ||
690 | |a antibiotic resistance | ||
690 | |a candida | ||
690 | |a <i>Enterobacteria</i> | ||
690 | |a <i>Enterococci</i> | ||
690 | |a <i>Klebsiella</i> | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 11, Iss 3, p 385 (2022) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/11/3/385 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/8fea1ce199a8458e8a93fa1f07875a2b |z Connect to this object online. |